<DOC>
	<DOCNO>NCT02070757</DOCNO>
	<brief_summary>This phase 3 , multicenter , prospective , randomize study intravenous ( IV ) ceftolozane/tazobactam vs. IV meropenem treatment adult participant either ventilator-associated bacterial pneumonia ( VABP ) ventilate hospital-acquired bacterial pneumonia ( HABP ) .</brief_summary>
	<brief_title>Safety Efficacy Study Ceftolozane/Tazobactam Treat Ventilated Nosocomial Pneumonia ( MK-7625A-008 )</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<mesh_term>Ceftolozane , tazobactam drug combination</mesh_term>
	<criteria>Key Adult participant diagnose either VABP ventilate HABP require IV antibiotic therapy ; Intubated mechanical ventilation time randomization ; New progressive infiltrate chest radiography consistent pneumonia ; Presence clinical criterion consistent diagnosis ventilate nosocomial pneumonia . Key History moderate severe hypersensitivity reaction betalactam antibiotic ; Prior nonstudy antibiotic &gt; 24 hour ; Gram stain low respiratory tract specimen show gram positive bacteria ; Active immunosuppression ; Endstage renal disease requirement dialysis ; Expected survival &lt; 72 hour ; Severe confound respiratory condition ( i.e. , chest trauma paradoxical respiration ) ; Known suspect communityacquired bacterial pneumonia . Anticipated concomitant use follow medication course study therapy : valproic acid divalproex sodium , serotonin reuptake inhibitor , tricyclic antidepressant , serotonin 5HT1 receptor agonist ( triptans ) , meperidine , buspirone . Receipt monoamine oxidase inhibitor within 14 day prior first dose study drug anticipate concomitant use course study therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Ventilator-associated bacterial pneumonia</keyword>
	<keyword>Hospital-acquired bacterial pneumonia</keyword>
	<keyword>Pneumonia</keyword>
	<keyword>Lung Diseases</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
	<keyword>Respiratory Tract Infections</keyword>
	<keyword>Infection</keyword>
	<keyword>Ventilator-Induced Lung Injury</keyword>
	<keyword>Lung Injury</keyword>
</DOC>